Skip to main content
VulnerabilityPublished

CVE-2026-19543: IBM Common Licensing · Improper Input Validation

Affects IBM Common LicensingSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 6.2 Medium.

Data as of 29 Oct 2026, 19:04 UTC

CVSS 3.1 base score
6.2Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.1% chance of exploitation in 30 days – higher than 6% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:L/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 14 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 29 Oct 2026.

What to do

Affected software

ProductAffectedFixed in
IBMCommon LicensingAffected
  • Agent 9.0 – ART 9.0.0.2
6 affected builds
Fixed in–

CPE configurations (2)

  • cpe:2.3:a:ibm:common_licensing:agent:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:common_licensing:art:*:*:*:*:*:*:*

AI-suggested

Until a fix is available, consider restricting access to the affected components and monitoring for anomalous input patterns that may indicate exploitation attempts.

Description

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 performs input validation exclusively on the client side and fails to enforce the same restrictions on the server side. An attacker can modify requests to bypass validation controls and submit unauthorized values, potentially resulting in unintended application behavior.

References

Community reviews

Loading reviews…